| Issue Date | Title | Author(s) |
| 2015 | Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 2015 | Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 2014 | Reforming the cancer drug fund focus on drugs that might be shown to be cost effective | Buxton, M; Longworth, L; Raftery, J; Sculpher, M; Towse, A |
| 2014 | Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: systematic review, statistical modelling and survey. | Longworth, L; Yang, Y; Young, T; Hernandez Alva, M; Mukuria, C; Rowen, D; Tosh, J; Tsuchiya, A; Evans, P; Keetharuth, A; Brazier, J |
| 2014 | Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey | Longworth, L; Yang, Y; Young, T; Mulhern, B; Hernandez, M; Mukuria, C; Rowen, D; Tosh, J; Tsuchiya, A; Evans, P; Keetharuth, A; Brazier, J |
| 2014 | Addressing liver disease in the UK: A blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis | Williams, R; Aspinall, R; Bellis, M; Camps-Walsh, G; Cramp, M; Dhawan, A; Ferguson, J; Forton, D; Foster, G; Gilmore, SI; Hickman, M; Hudson, M; Kelly, D; Langford, A; Lombard, M; Longworth, L; Martin, N; Moriarty, K; Newsome, P; O'Grady, J; Pryke, R; Rutter, H; Ryder, S; Sheron, N; Smith, T |
| 2014 | Cost-effectiveness of upcoming treatments for hepatitis C: We need to get the models right | Tsochatzis, EA; Crossan, C; Longworth, L |
| 2012 | A review of generic preference-based measures of health-related quality of life in visual disorders | Tosh, J; Brazier, J; Evans, P; Longworth, L |
| 2013 | When does NICE recommend the use of health technologies within a programme of evidence development? | Longworth, L; Youn, J; Bojke, L; Palmer, S; Griffin, S; Spackman, E; Claxton, K |
| 2015 | Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: A Single Technology Appraisal. Evidence Review Group Report to NICE | Greenhalgh, J; Longworth, L; Crossan, C; Singh, J; Bagust, A; Beale, S; Richardson, M; Banks, L; Kotas, E; Hall, M |
